Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for Everest Medicines’ ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.

SHANGHAI, China I March 23, 2025 I Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 202 ...

US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an almost miraculous protection against a virus, which killed millions around the world. Aided by expedited ...

The team showed that these DNA-LNPs demonstrate a unique way of priming the immune system compared to mRNA and protein-in-adjuvant formulations. The DNA-LNP induced a unique activation pattern of ...